Catherine Bresson

Director, Operational Team, WIN Consortium

Wafik El-Deiry

Chair, WIN Consortium; Director, Legorreta Cancer Center at Brown University (USA)

Razelle Kurzrock

Chief Medical Officer, WIN Consortium; Prof. of Medicine, Associate Director Clinical Research, MCW Cancer Center and Linda T. & John A. Mellowes Chair of Precision Oncology (USA)

Yves A. Lussier

Chairman, Scientific Advisory Board, WIN Consortium; Professor and Chair, Department of Biomedical Informatics, The University of Utah School of Medicine (USA)

Jacques Raynaud

Senior adviser to WIN Strategy, Science and Fundraising, WIN Consortium

Richard L. Schilsky

Chair Emeritus, WIN Consortium; Professor Emeritus, University of Chicago; past President and former Executive Vice President & Chief Medical Officer (ASCO) (USA)

Marina Sekacheva

Head of the Membership Committee, WIN Consortium; Director of Personalized Oncology Institute, I.M. Sechenov First Moscow State Medical University, Sechenov University (Russia)

Catherine Bresson

Director, Operational Team, WIN Consortium

Layla El-Gharras

Assistant, Operational Team, WIN Consortium

Shai Magidi

IT Data Management, WIN Consortium

Eitan Rubin

Head of Bioinformatics, WIN Consortium; Associate Professor, Ben-Gurion University of the Negev (Israel)

Fanny Wunder

Project Manager, WIN Consortium

Gerald Batist

Director, McGill Centre for Translational Research in Cancer and of the Segal Cancer Centre, Jewish General Hospital (Canada)

Ioana Berindan-Neagoe

Director of Research Center of Functional Genomics, Biomedicine and Translational Medicine, The University of Medicine and Pharmacy Iuliu Hatieganu (Romania)

Anton Buzdin

Head of Laboratory for Clinical Genomic Bioinformatics; Head of Genomic Center; Sechenov First Moscow Medical University (Russia)

Benedito A. Carneiro

Co-Leader Cancer Therapeutics Program, Legorreta Cancer Center at Brown University (USA)

Stanley R. Hamilton

Vice Chair, Scientific Advisory Board, WIN Consortium; Professor, Department of Pathology, City of Hope Comprehensive Cancer Center (USA)

Roy S. Herbst

Ensign Professor of Medicine; Chief of Medical Oncology; Deputy Director of Yale Cancer Center and Smilow Cancer Hospital (USA)

Paul Hofman

Professor of Pathology, Nice Sophia Antipolis University (France)

Yves A. Lussier

Chairman, Scientific Advisory Board, WIN Consortium; Professor and Chair, Department of Biomedical Informatics, The University of Utah School of Medicine (USA)

John Quackenbush

Henry Pickering Walcott Professor of Computational Biology and Bioinformatics and Chair, Dept of Biostatistics, Harvard T.H Chan School of Public Health (USA)

Gideon Rechavi

Head, Sheba Cancer Research Center, Sheba Medical Center (Israel)

Eytan Ruppin

Branch Chief, Cancer Data Science Laboratory (CDSL), National Institute of Health (NIH) (USA)

Lillian Siu

Professor, University of Toronto, Medical Oncologist, Princess Margaret Cancer Centre, Director, Phase I Program BMO Financial Group Chair in Precision Genomics (Canada)

Zhen Chen

Vice President, Fudan University Shanghai Cancer Center (China)

Cristiano de Pádua Souza

Medical Oncologist, Department of Oncology, Fundaçao Pio XII - Hospital de Câncer de Barretos (Brazil)

Wafik El-Deiry

Chair, WIN Consortium; Director, Legorreta Cancer Center at Brown University (USA)

Tobias Meissner

Cancer Genomics Manager, Avera Cancer Institute (USA)

Ni Ming

Director, Office of Shanghai Anti-cancer and Office of International Affairs, Fudan University Shanghai Cancer Center (China)

Alejandro Piris

Chief Scientific Officer, Vall d'Hebron Institute of Oncology, VHIO (Spain)

Angel Porgador

Professor and Dean, Faculty of Health Sciences, Ben-Gurion University of the Negev (Israel)

C.S. Pramesh

Director, Tata Memorial Hospital; Professor, Thoracic Surgery, Division of Surgical Oncology, Tata Memorial Centre (India)

Eitan Rubin

Head of Bioinformatics, WIN Consortium; Associate Professor, Ben-Gurion University of the Negev (Israel)

Pierre Saintigny

Medical Oncologist, Professor of Medicine at University Claude Bernard Lyon, Coordinator of the Translational Medicine Unit at Centre Léon Bérard (France)

Marina Sekacheva

Head of the Membership Committee, WIN Consortium; Director of Personalized Oncology Institute, I.M. Sechenov First Moscow State Medical University, Sechenov University (Russia)

Benjamin M. Solomon

Medical Oncologist, Avera Cancer Institute (USA)

Hikmat Abdel-Razeq

Professor and Chairman, Department of Medicine, Chief Medical Officer and Deputy Director General King Hussein Cancer Center (Jordan)

Amal Al Omari

Chief Scientific Officer, King Hussein Cancer Center (Jordan)

Humaid Al-Shamsi

Chief Executive Officer of Burjeel Cancer Institute (UAE & GCC), (United Arab Emirates)

Satoru Aoyama

Assistant Professor, Institute of Science Tokyo Hospital (Japan)

Jair Bar

Head, Thoracic Oncology, Institute of Oncology, Sheba Medical Center (Israel)

Gerald Batist

Director, McGill Centre for Translational Research in Cancer and of the Segal Cancer Centre, Jewish General Hospital (Canada)

Guy Berchem

Medical Director, Centre Hospitalier de Luxembourg; Associate Medical Director, Luxembourg Institute of Health (Luxembourg)

Raanan Berger

Director, Institute of Oncology, Sheba Medical Center (Israel)

Ioana Berindan-Neagoe

Director of Research Center of Functional Genomics, Biomedicine and Translational Medicine, The University of Medicine and Pharmacy Iuliu Hatieganu (Romania)

Jean-Yves Blay

General Director, Centre Léon Bérard (France)

Rares Buiga

Head of Pathology Department, The Oncology Institute Ion Chiricuta (IOCN) (Romania)

Anca Dana Buzoianu

Rector, The University of Medicine and Pharmacy Iuliu Haţieganu (Romania)

David Cantú de León

Director of Research, Instituto Nacional de Cancerologia (INCan)(Mexico)

Benedito A. Carneiro

Co-Leader Cancer Therapeutics Program, Legorreta Cancer Center at Brown University (USA)

Andrés Cervantes

Head of Department, INCLIVA (Spain)

Zhen Chen

Vice President, Fudan University Shanghai Cancer Center (China)

William L. Dahut

Chief Scientific Officer, American Cancer Society (USA)

Cristiano de Pádua Souza

Medical Oncologist, Department of Oncology, Fundaçao Pio XII - Hospital de Câncer de Barretos (Brazil)

Said Dermime

Senior Scientist/ Director of Translational Cancer Research Facility, National Center for Cancer Care & Research Hamad Medical Corporation (Qatar)

Wafik El-Deiry

Chair, WIN Consortium; Director, Legorreta Cancer Center at Brown University (USA)

Carol Farhangfar

Assistant Vice President, Translational Research, Wake Forest Baptist Comprehensive Cancer Center/Atrium Health (USA)

Amanda Ferraro

Patient Advocate, Author, Freelance Writer, Cancer is an A* LLC (USA)

Naftali Z. Frankel

Director of Precision Medicine Innovation, Chaim Medical Resource, Org, (USA)

Himabindu Gaddipati

Founder and Managing Director, Vyas Cancer Research Pvt (VCR Park) (India)

Manon Gantenbein

Head of Clinical and Epidemiological Investigation Center (CIEC) & Clinical Project Management Office (CPMO), Luxembourg Institute of Health (Luxembourg)

Eugenia Girda

Assistant Professor of Obstetrics, Gynecology and Reproductive Sciences and Division of Gynecologic Oncology, Rutgers Cancer Institute of New Jersey (CINJ), (USA)

Kerri Gober

Associate Chief of Staff, Discovery, American Cancer Society (USA)

Leah Graham

Program Director, Maine Cancer Genomics Initiative, The Jackson Laboratory (USA)

Sadakatsu Ikeda

Professor, Department Chief, Department of Precision Cancer Medicine, Institute of Science Tokyo Hospital (Japan)

Simon Istolainen

Chief Strategy and Scientific Network, Cure51 (France)

Anthony Joshua

Head of Department, Department of Medical Oncology, The Kinghorn Cancer Centre, St Vincent's Hospital (Australia)

Mandar Kulkarni

CEO and Director, Vyas Cancer Research Pvt (VCR Park) (India)

Sewanti Limaye

Director of Medical & Precision Oncology, Director Oncology, Director Clinical & Translational Oncology Research, Sir H.N. Reliance Foundation Hospital & Research Centre (India)

Jia Liu

Staff Specialist Medical Oncology and Translational Lead of Phase 1 Unit, The Kinghorn Cancer Center, St Vincent's Hospital (Australia)

Chetan Madre

Oncology Research- Manager, Sir H.N. Reliance Foundation Hospital & Research Centre (India)

Juan Martín-Liberal

Consultant Medical Oncologist Melanoma, Sarcoma and GU Tumors Unit Early Drug Development Unit, Catalan Institute of Oncology (ICO)(Spain)

Ruben A. Mesa

President, Atrium Health Levine Cancer Executive Director, Atrium Health Wake Forest Baptist Comprehensive Cancer Center (USA)

Tobias Meissner

Cancer Genomics Manager, Avera Cancer Institute (USA)

Ni Ming

Director, Office of Shanghai Anti-cancer and Office of International Affairs, Fudan University Shanghai Cancer Center (China)

Khaled Musallam

Group Chief Research Officer, Burjeel Holdings, Founding Director, Center for Research on Rare Blood Disorders (CR-RBD); Burjeel Medical City (United Arab Emirates)

Amir Onn

Head of Standard Operating Procedures and Repository Committee, WIN Consortium; Chair, Institute of Pulmonary Oncology, Sheba Medical Center (Israel)

Jim Palma

Chief Executive Officer of TargetCancer Foundation (USA)

Alejandro Piris

Chief Scientific Officer, Vall d'Hebron Institute of Oncology, VHIO (Spain)

Angel Porgador

Professor and Dean, Faculty of Health Sciences, Ben-Gurion University of the Negev (Israel)

C.S. Pramesh

Director, Tata Memorial Hospital; Professor, Thoracic Surgery, Division of Surgical Oncology, Tata Memorial Centre (India)

Rui Manuel Reis

Scientific Director, Fundaçao Pio XII - Hospital de Câncer de Barretos (Brazil)

Gregory Riedlinger

Associate Professor of Pathology and Laboratory Medicine, Rutgers Cancer Institute of New Jersey (CINJ), (USA)

Abdul Rouf

Senior Research Scientist – Director of Clinical Trial Unit, National Center for Cancer Care & Research Hamad Medical Corporation (Qatar)

Eitan Rubin

Head of Bioinformatics, WIN Consortium; Associate Professor, Ben-Gurion University of the Negev (Israel)

Jens Rueter

Chief Medical Officer, Jackson Laboratory & Medical Director – Maine Cancer Genomics Initiative, The Jackson Laboratory (USA)

Pierre Saintigny

Medical Oncologist, Professor of Medicine at University Claude Bernard Lyon, Coordinator of the Translational Medicine Unit at Centre Léon Bérard (France)

Ramón Salazar

General Director, Catalan Institute of Oncology (ICO)(Spain)

Mohamed E. Salem

Clinical Associate Professor, Hematology and Oncology, Wake Forest Baptist Comprehensive Cancer Center/Atrium Health (USA)

Pessie Schlafrig

Co-founder and Director, Chaim Medical Resource, Org (USA)

Marina Sekacheva

Head of the Membership Committee, WIN Consortium; Director of Personalized Oncology Institute, I.M. Sechenov First Moscow State Medical University, Sechenov University (Russia)

Manju Sengar

Professor, Medical Oncology - Tata Memorial Center (India)

Shambhavi Singh

Precision Oncology Research Fellow, Division of Precision Oncology and Medical Oncology, Sir H N Reliance Foundation Hospital and Research Centre (India)

Benjamin M. Solomon

Medical Oncologist, Avera Cancer Institute (USA)

Andrey A. Svistunov

First Vice Rector, I.M Sechenov First Moscow State Medical University (Russia)

Josep Tabernero

Head, Medical Oncology Department, Vall d'Hebron University Hospital (HUVH); Director, Vall d'Hebron Institute of Oncology, VHIO (Spain)

Mohammed Ussama Al Homsi

Senior Consultant Oncology, National Center for Cancer Care & Research Hamad Medical Corporation (Qatar)

Catalin Vlad

General Manager of Oncology, The Oncology Institute Ion Chiricuta (IOCN) (Romania)

Nicolas Wolikow

Chief Executive Officer, Cure51 (France)